2.4 mg semaglutide to tirzepatide equivalent dose Semaglutide Dosage Chart for Weight Loss & Dosing Guide Switching from semaglutide to tirzepatide

Recent global statistics reveal that over 1 billion individuals are affected by obesity, including approximately 880 million adults and 159 million children and adolescents as of 2022 [4]

Follow the link below to learn more about switching between GLP-1 medications and what to expect during the process: Like all medicines, this medicine can cause side effects, although not everybody gets them

Disclaimer: Weight loss results are not guaranteed and depend on adherence, metabolic response, and clinical evaluation

It may also make your depression or anxiety symptoms worse

This 2.4 mg dose is the maintenance target in clinical trials and is the dose at which most patients achieve their optimal weight loss response

PBH characteristically occurs postprandially, particularly after consuming refined carbohydrates, sugary foods, or alcohol